Oral Answers to Questions

Andrew Griffiths Excerpts

Wednesday 13th March 2019 Commons Chamber

[The Prime Minister]

I am sure that everybody across the House sends their sympathies and concerns to the family of Maryam. We recognise that this must be an incredibly difficult time. Decisions on such matters are rightly taken not by politicians but by clinicians. I understand that the hon. Lady recently met my right hon. Friend the Health Secretary, and as she says, NICE considered the relevant information and recommendations at its appraisal committee meeting on 6 March. It is right, however, that the benefits and evidence in relation to new medicines be properly considered by the experts and clinicians in the field. The Department of Health and Social Care is working with NICE on this issue.

[Andrew Griffiths (Burton) (Con)]

My constituent Nicola Morgan-Dingley is a wife and mum. She was just 36 when she was diagnosed with triple negative breast cancer, the most virulent form, and, sadly, at 38, she has a terminal diagnosis. Nicola has asked me to ask three things today. First, will the Prime Minister consider publicising the fact that women should never miss a mammogram and the importance of attending? Secondly, will she consider lowering the age at which women can seek a mammogram so that more women are not missed out? Thirdly, there are some immunotherapy trials taking place across the country that could offer a lifeline to Nicola. Will she consider expanding those trials so that Nicola can get the help that could save her life?

[The Prime Minister]

I am sure the whole House shares my hon. Friend’s concern for his constituent Nicola. Our sympathies are with her and her family and friends. She asked about three things. On the age at which a screening becomes available or is required, that matter has been considered previously and I am sure will be considered again as part of the long-term plan, but I understand that the decision is based on the evidence of the benefits of screenings at certain ages.

My hon. Friend referenced immunotherapy. To date, the National Institute for Health Research has delivered 64 studies of immunotherapy for women with breast cancer, 28 studies are being opened up to recruitment and 14 studies are currently in set-up, but I will ask the Department to respond to him on the specific case of his constituent. On the third point, Nicola is absolutely right. I would urge all women to attend their mammogram appointments—they are vital: they could save your life.